Journal article Open Access

Absorbed Dose Measurement in Gonads Menduring Abdominal and Pelvicradiotherapy

Sadegh Masoudi; Ali Asghar Yousefi; Somayeh Nourollahi; Fatemeh Noughani


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">Hermann RM, Henkel K, Christiansen H, et al. Testicular dose and 
hormonal changes after radiotherapy of rectal cancer. RadiotherOncol 
2005;75:83–8.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">Rowley MJ, Leach DR, Garner GA, Heller CG. Effects of graded doses 
of ionizing radiation on the human testis. Radiat Res 1974;59:665–78.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">Clifton DK, Brenner WJ. The effect of testicular X-irradiation on 
spermatogenesis in man: a comparison with the mouse. J Androl 
1983;4:387–92.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">Herrmann T. Radiation reactions in the gonads: importance in patient 
counseling. StrahlentherOnkol 1997;173:493–501.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">Piroth MD, Hensley F, Wannenmacher M, Zierhut D. Male gonadal 
dose in adjuvant 3-d-pelvic irradiation after anterior resection of rectal 
cancer. Influence to fertility. Strahlenther Onkol 2003;179:754–9.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">Izard MA. Leydig cell function and radiation: a review of the literature. 
RadiotherOncol 1995;34:1–8.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">Dueland S, Guren MG, Olsen DR, Poulsen JP, MagneTveit K. Radiation 
therapy induced changes in male sex hormone levels in rectal cancer 
patients. RadiotherOncol 2003;68:249–53.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">M. Mazonakis, G. Kokona,et al "Testicular dose and associated risk 
from inverted-Y field irradiation in patients with Hodgkin's 
disease"PhysicaMedica,. Vol. XXI, N. 4, October-December 2005</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="x">Committee on the Biological Effects of Ionizing Radiation: The Effects 
on Populations of Exposure to Low Levels of Ionizing Radiation. 
Washington, DC, National Academy of Sciences, National Research 
Council, 1990 
[10] International Commission on Radiological Protection: Report of the 
Task Group on Risk Estimation for Multifactorial Diseases, ICRP 
Publication 83, Annals of the ICRP 29(3-4), Oxford, Pergamon Press, 
1999 
[11] Sankaranarayanan K, Chakraborty R: Ionizing radiation and genetic 
risks. XIII. Summary and synthesis of papers VI to XII and estimates of 
genetic risks in the year 2000. Mutat Res 453:183-197, 2000 
[12] Sankaranarayanan K, Chakraborty R: Ionizing radiation and genetic 
risks. XI. The doubling dose estimates from the mid-1950s to the present 
and the conceptual change to the use of human data for spontaneous 
mutation rates and mouse data for induced rates for doubling dose 
calculations. Mutat Res 453:107-127, 2000 
[13] Sankaranarayanan K, Chakraborty R: Ionizing radiation and genetic 
risks. XII. The concept of potential recoverability correction factor 
(PRCF) and its use for predicting the risk of radiation-inducible genetic 
diseases in human live births. Mutat Res 453:129-179, 2000 
[14] Hall, Eric J.; Giaccia, Amato J" Radiobiology for the Radiologist, 6th 
Edition" Copyright ©2006 Lippincott Williams &amp; Wilkins 
[15] Busuoli G. General characteristics of TL materials. In: Oberhofer M, 
Scharmann A, editors. Applied thermoluminescencedosimetry: lectures 
of a course held at the Joint Research Centre, Ispra, 12–16 November 
1979, 87. Bristol: Adam Hilger Ltd; 1981. (fig. 5.4(c)). 
[16] Centola G M, Keller J W, Henzler M, Rubin P. Efect of low-dose 
testicular irradiation on sperm count and fertility in patients with 
testicular seminoma. J Androl 1994: 15; 608-613. 
[17] Howell S, Shalet S. Gonadal damage from chemotherapyand 
radiotherapy. EndocrinolMetabClin North Am 1998: 27; 927-943. 
[18] Rowley M J, Leach D R, Warner G A, Heller C G. Effectof graded doses 
of ionizing radiation on the human testis. Radiat Res 1974: 59; 665-678. 
[19] Hansen P V, Trykker H, Svennekjaer I L, HvolbyJ. Longterm recovery 
of spermatogenesis after radiotherapy in patients with testicular cancer. 
RadiotherOncol 1990: 18; 117-125. 
[20] Ash R The influence of radiation on fertility in man. BrJ Radiol 1980: 
53; 271-278.</subfield>
  </datafield>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Absorbed Dose</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Abdominal and pelvic</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">gonads men</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Radiotherapy.</subfield>
  </datafield>
  <controlfield tag="005">20200120172212.0</controlfield>
  <controlfield tag="001">1088006</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ali Asghar Yousefi</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Somayeh Nourollahi</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Fatemeh Noughani</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">189793</subfield>
    <subfield code="z">md5:3d06793ac5b508c2908a4cbca8c625f3</subfield>
    <subfield code="u">https://zenodo.org/record/1088006/files/16877.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2013-10-01</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="p">user-waset</subfield>
    <subfield code="o">oai:zenodo.org:1088006</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Sadegh Masoudi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Absorbed Dose Measurement in Gonads Menduring Abdominal and Pelvicradiotherapy</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-waset</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;Two different testicular tissues have to be distinguished in regard to radiation damage: first the seminiferous tubules, corresponding to the sites of spermatogenesis, which are extremely radiosensitive. Second the testosterone secreting Leydig cells, which are considered to be less radiosensitive. This study aims to estimate testicular dose and the associated risks for infertility and hereditary effects from Abdominal and pelvic irradiation. Radiotherapy was simulated on a humanoid phantom using a 15 MV photon beam. Testicular dose was measured for various field sizes and tissue thicknesses along beam axis using an ionization chamber and TLD. For transmission Factor Also common method of measuring the absorbed dose distribution and electron contamination in the build-up region of high-energy beams for radiation therapy is by means of parallel-plate Ionisation chambers. Gonadal dose was reduced by placing lead cups around the testes supplemented by a field edge block. For a tumor dose of 100 cGy, testicular dose was 2.96-8.12 cGy depending upon the field size and the distance from the inferior field edge. The treatment at parameters, the presence of gonad shield and the somatometric characteristics determine whether testicular dose can exceed 1 Gy which allows a complete recovery of spermatogenesis.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.1088005</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.1088006</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>
53
15
views
downloads
All versions This version
Views 5354
Downloads 1515
Data volume 2.8 MB2.8 MB
Unique views 5051
Unique downloads 1414

Share

Cite as